Clinical Trial Update: Immune Response to Mycobacterium Tuberculosis Infection

View source ↗

Summary

Clinical trial update reporting the completion of a study on the immune response to Mycobacterium tuberculosis infection in latent TB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Latent Tuberculosis | Status: COMPLETED